For the pharmaceutical industry, the prevalence of counterfeit drugs can represent loss of reputation, loss of valuable R&D efforts and intellectual property, loss of revenue, and increased costs. Sue Lee of World Courier asks what can pharmaceutical professionals do to ensure that their organisations and the patients they serve are not impacted by counterfeit drugs? The answer is to identify their highest risk products and shipments and to secure their supply chain to the fullest extent possible.
http://ipimediaworld.com/wp-content/uploads/2014/07/Maintaining.pdf